Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status.
Satoshi IkedaHiroshige YoshiokaSatoshi IkeoMitsunori MoritaNaoyuki SoneTakashi NiwaAkihiro NishiyamaToshihide YokoyamaAkimasa SekineTakashi OguraTadashi IshidaPublished in: BMC cancer (2017)
In the elderly NSCLC patients with poor PS, serum albumin levels may help identify certain patient populations more likely to receive a survival benefit of systemic chemotherapy.